Today’s price, $27.54, sits below the range. 22.0% below the $35.32 the four methods put it at.
UNDERVALUEDThe real sections, opened with your free account.
The 3 methods put Pfizer’s fair value around $35.32 a share.
Is it growing? Over the last 3 years, Pfizer's sales have shrunk about 15% a year. In its latest quarter (Q3 '26), sales were about 0.4% lower than the same quarter a year earlier.
Does it make money? Yes. Of every dollar of sales, Pfizer keeps about 75 cents after making the product, 29 cents after running the business and 6 cents as profit after everything, tax included.
Latest report: July to September 2026 (quarter ended Sep 27, 2026), reported Nov 3, 2026 before the open.
Reported, not read yet. The company reported July to September 2026 results (quarter ended Sep 27, 2026) on Nov 3, 2026, before the open. The reading of its filing usually appears by the next morning. Until then the figures here are the ones already published.
From the company's quarterly statements through Sep 30, 2026.
The full read in the IV Calculator adds what the filing said that the headlines skipped, margins and cash for the quarter, how each part of the business did, and how PFE moved after its last eight reports.
See PFE’s full earnings read, free →